Scrip 100

The latest Scrip 100 data set is now available and includes data on R&D spending, total revenues, employee numbers and sales for the top 100 biopharmaceutical companies (based on FY 2022). If you are a subscriber, you may download the data in Excel format.


View Ranking

Industry Leaderboard Gains And Dips Were Still Marked By COVID-19

 
• By Jessica Merrill and Edwin Elmhirst

Pfizer held the number one spot on the Scrip 100 on the strength of its COVID-19 products, while some others faced challenging financial comparisons in 2022 because of COVID-19 headwinds.

Scrip 100: By The Numbers

 
• By Lucie Ellis-Taitt and Kosh Naran

Pfizer dominated the Scrip 100 rankings of the top pharmaceutical companies in the world based on full year 2022 pharmaceutical sales, driven by its COVID-19 success.

Scrip 100 Ranking